Big congrats to Veale/Fearon team members Brianne Barker and Megan Hanlon who won poster and bright sparks awards at #ECI2024 on circulatory ‘PRIME’ cells and synovial tissue macrophages in patients with RA School of Medicine, Trinity College Dublin Arthritis Ireland TCD TBSI #athriris #fibroblasts #macrophages

Great transatlantic teamwork last week - thank you so much to Prof Fearon for presenting our latest work examining myeloid tissue signatures between Rheumatoid and Psoriatic Arthritis at the ISR congress and even better to receive a poster prize for our first time presenting it!

In-depth analysis of myeloid cells residing within the rheumatoid arthritis joint reveals a unique early signature associated with disease activity Science Advances Megan Hanlon science.org/doi/10.1126/sc…

New research from @moleculartcd + St Vincent's University Hospital (SVUH) published in Science Advances offers potential for early diagnosis + therapeutic intervention for rheumatoid #arthritis. You can read more here: tcd.ie/news_events/ar… #TrinityExperts #researchMATTERS #LoveIrishResearch

A new study shows that the presence of a CD40-expressing CD206+CD163+ macrophage population dominates the inflamed #RheumatoidArthritis synovium which is associated with disease activity and treatment response. Enjoy the research highlights from the lead author: 👇

Thanks to Irish Independent for highlighting our latest research on early myeloid signatures in RA. This work was funded by my We are now Research Ireland enterprise fellowship, as well as funding from HealthResearchBoard SFI and Arthritis Ireland independent.ie/irish-news/hea…

Thrilled to share I’ve been awarded Arthritis National Research Foundation fellowship to investigate pathogenic myeloid subsets in RA. I’m honored to be supported by such an amazing foundation and to be recognized as the Gale "Morrie" Granger Memorial Fellow! curearthritis.org/scientists/meg…

Meet Dr. Megan Hanlon , a Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, passionate about uncovering early clues and new treatment targets for Rheumatoid Arthritis (RA). With the support of ANRF, Dr. Hanlon is investigating a unique type of